Gene · 9
NAT1: N-acetyltransferase 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. NAT1: N-acetyltransferase 1. Genes, record 9. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/9
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P18440 | Arylamine N-acetyltransferase 1 | 290 | 2 | Ensembl, GeneID, HGNC |
Source UniProt
Patents71
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 54868 | P18440 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 54869 | P18440 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 54870 | P18440 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 54871 | P18440 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 54872 | P18440 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 54873 | P18440 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 54874 | P18440 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 4480 | P18440 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 4480 | P18440 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 54871 | P18440 | Espacenet |
1 to 10 of 71
See all 71 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants971
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | NAT1 papers | Newest fiscal year |
|---|---|---|---|
| T32ES011564 | UOFL ENVIRONMENTAL HEALTH SCIENCES TRAINING PROGRAM | 28 | 2025 |
| P20GM113226 | Hepatobiology and Toxicology COBRE | 21 | 2025 |
| P42ES023716 | Environmental Exposure and Cardiometabolic Disease | 16 | 2025 |
| P30ES006694 | Southwest Environmental Health Sciences Center | 10 | 2025 |
| P50AA024337 | The Role of Nutrition in the Development/Progression of Alcohol-Induced Organ Injury | 10 | 2025 |
| P50CA058223 | SPORE in Breast Cancer | 9 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 6 | 2025 |
| P30CA023074 | University of Arizona Cancer Center - Cancer Center Support Grant | 6 | 2025 |
| P30ES010126 | UNC Center for Environmental Health and Susceptibility | 5 | 2025 |
| P30CA016086 | Cancer Center Support Grant | 4 | 2025 |
1 to 10 of 971Source NIH's project files
See all 971 nih grantsPapers1,709
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of anoikis-related and cell matrix adhesion genes in the progression of colon adenocarcinoma using bioinformatics analysis. | Comput Methods Biomech Biomed Engin | 2026 | 42775455 | PubTator, text mining | PubMed |
| Association of Selected Genetic Variants in CYP1A1, CYP2D6, NAT1 and NAT2 with Endometrial Cancer Risk: A Preliminary Case-Control Study. | Int J Mol Sci | 2026 | 42450020 | PubTator, text mining | PubMed |
| Regulation of NAT1 activity in modern humans by a novel phosphorylation site. | Sci Adv | 2026 | 42247510 | PubTator, text mining | PubMed |
| eIF4G2-Dependent Translation Restrains Pancreatic Cancer Progression. | Cancer Res | 2026 | 42202060 | PubTator, text mining | PubMed |
| Prognostic model construction and drug prediction in colorectal cancer using mitochondrial programmed cell death-related genes. | Clin Transl Oncol | 2026 | 42184077 | PubTator, text mining | PubMed |
| Mitochondrial Quality Control and Metabolic Reprogramming in Hepatocellular Carcinoma: Implications for Immunotherapy and Treatment Resistance. | Cells | 2026 | 41892308 | PubTator, text mining | PubMed |
| Alternative polyadenylation links RNA processing to iron metabolism in human erythropoiesis. | Nucleic Acids Res | 2026 | 41805127 | PubTator, text mining | PubMed |
| Ultrasound-Responsive Serotonylation and Hallmark Pathway Gene Signatures Reveal Tumor Microenvironment Vulnerabilities and Prognostic Subtypes in Colorectal Cancer. | Cancer Biother Radiopharm | 2026 | 41742646 | PubTator, text mining | PubMed |
| A genetic screen for modifiers of cohesin clustering identifies regulators of genome folding. | Sci Adv | 2026 | 41616049 | PubTator, text mining | PubMed |
| Indian-enriched genetic variants are associated with cognitive function. | Alzheimers Dement | 2026 | 41612616 | PubTator, text mining | PubMed |
1 to 10 of 1,709
See all 1,709 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/9
GET https://conductscience.org/api/genes/v1/9/patents?page=2